As of 2026-03-23, the Relative Valuation of Rapid Dose Therapeutics Corp (DOSE.CN) is 0.01 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of Rapid Dose Therapeutics Corp based on Relative Valuation is -88.1%.
The range of the Relative Valuation is (0.01) - 0.02 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 0.5x | 0.4x |
| Forward P/E multiples | -1.5x - -0.7x | -1.1x |
| Fair Price | (0.01) - 0.02 | 0.01 |
| Upside | -110.8% - -75.6% | -88.1% |
| Date | P/E |
| 2026-03-20 | -3.11 |
| 2026-03-19 | -2.95 |
| 2026-03-18 | -3.11 |
| 2026-03-17 | -3.11 |
| 2026-03-16 | -3.26 |
| 2026-03-13 | -3.42 |
| 2026-03-12 | -3.57 |
| 2026-03-11 | -3.57 |
| 2026-03-10 | -3.26 |
| 2026-03-09 | -3.42 |
| 2026-03-06 | -3.73 |
| 2026-03-05 | -3.57 |
| 2026-03-04 | -4.19 |
| 2026-03-03 | -4.50 |
| 2026-03-02 | -4.66 |
| 2026-02-27 | -4.66 |
| 2026-02-25 | -4.19 |
| 2026-02-24 | -4.35 |
| 2026-02-23 | -4.35 |
| 2026-02-20 | -4.50 |
| 2026-02-19 | -4.66 |
| 2026-02-18 | -4.97 |
| 2026-02-17 | -4.97 |
| 2026-02-13 | -4.81 |
| 2026-02-12 | -4.19 |
| 2026-02-11 | -4.35 |
| 2026-02-10 | -4.97 |
| 2026-02-05 | -4.50 |
| 2026-02-04 | -4.35 |
| 2026-02-03 | -4.35 |
| 2026-02-02 | -4.35 |
| 2026-01-29 | -4.50 |
| 2026-01-28 | -4.50 |
| 2026-01-26 | -4.35 |
| 2026-01-22 | -4.50 |
| 2026-01-21 | -4.81 |
| 2026-01-20 | -4.66 |
| 2026-01-19 | -4.50 |
| 2026-01-16 | -4.97 |
| 2026-01-15 | -4.35 |
| 2026-01-14 | -4.19 |
| 2026-01-13 | -4.04 |
| 2026-01-12 | -4.50 |
| 2026-01-08 | -4.19 |
| 2026-01-07 | -4.04 |
| 2026-01-06 | -4.50 |
| 2026-01-05 | -4.50 |
| 2026-01-02 | -4.35 |
| 2025-12-31 | -4.04 |
| 2025-12-30 | -4.04 |